However, in contrast, androgen-receptor signaling can also promote tumor progression under certain conditions, especially in triple-negative breast cancer (TNBC), where AR expression is often associated with more aggressive disease and poorer outcomes [59,63,64]. Here, AR is linked to triple-negative breast carcinoma.